Open AccessBevacizumab as a second- or later-line of treatment for metastatic colorectal cancer
Author(s) -
Lee Chun Park
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i10.1104
Subject(s) - bevacizumab , medicine , colorectal cancer , chemotherapy , oncology , progression free survival , cancer , surgery , gastroenterology
To determine the efficacy of bevacizumab in patients with metastatic colorectal cancer (MCRC) who have failed prior chemotherapy without bevacizumab.